A Mechanism of O-Demethylation of Aristolochic Acid I by Cytochromes P450 and Their Contributions to This Reaction in Human and Rat Livers: Experimental and Theoretical Approaches.

作者: Marie Stiborová , František Bárta , Kateřina Levová , Petr Hodek , Heinz Schmeiser

DOI: 10.3390/IJMS161126047

关键词:

摘要: Aristolochic acid I (AAI) is a plant alkaloid causing aristolochic nephropathy, Balkan endemic nephropathy and their associated urothelial malignancies. AAI detoxified by cytochrome P450 (CYP)-mediated O-demethylation to 8-hydroxyaristolochic (aristolochic Ia, AAIa). We previously investigated the efficiencies of human rat CYPs in presence two other components mixed-functions-oxidase system, NADPH:CYP oxidoreductase b5, oxidize AAI. Human CYP1A are major enzymes oxidizing Other such as CYP2C, 3A4, 2D6, 2E1, 1B1, also form AAIa, but with much lower efficiency than CYP1A. Based on velocities AAIa formation examined expression levels livers, here we determined contributions individual oxidation these organs. CYP1A2 followed CYP2C9, 3A4 1A1 were contributing liver, while CYP2C 1A most important liver. employed flexible silico docking methods explain differences liver CYP1A1, 1A2, 2C9, that all O-demethylate AAI, different effectiveness. found binding orientations methoxy group centers CYP energies active sites dictate oxidation. Our results indicate utilization experimental theoretical an appropriate study design examine CYP-catalyzed reaction mechanisms hepatic this metabolism.

参考文章(90)
V. M. Arlt, M. Stiborova, J. vom Brocke, M. L. Simoes, G. M. Lord, J. L. Nortier, M. Hollstein, D. H. Phillips, H. H. Schmeiser, Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer Carcinogenesis. ,vol. 28, pp. 2253- 2261 ,(2007) , 10.1093/CARCIN/BGM082
Kateřina Levová, Michaela Moserová, Věra Kotrbová, Miroslav Šulc, Colin J. Henderson, C. Roland Wolf, David H. Phillips, Eva Frei, Heinz H. Schmeiser, Jaroslav Mareš, Volker M. Arlt, Marie Stiborová, Role of Cytochromes P450 1A1/2 in Detoxication and Activation of Carcinogenic Aristolochic Acid I: Studies with the Hepatic NADPH:Cytochrome P450 Reductase Null (HRN) Mouse Model Toxicological Sciences. ,vol. 121, pp. 43- 56 ,(2011) , 10.1093/TOXSCI/KFR050
Lesley A. McLaughlin, Sebastien Ronseaux, Robert D. Finn, Colin J. Henderson, C. Roland Wolf, Deletion of Microsomal Cytochrome b5 Profoundly Affects Hepatic and Extrahepatic Drug Metabolism Molecular Pharmacology. ,vol. 78, pp. 269- 278 ,(2010) , 10.1124/MOL.110.064246
Lesley A. McLaughlin, C. Roland Wolf, Colin J. Henderson, Evidence that cytochrome b5 and cytochrome b5 reductase can act as sole electron donors to the hepatic cytochrome P450 system. Molecular Pharmacology. ,vol. 83, pp. 1209- 1217 ,(2013) , 10.1124/MOL.112.084616
Helena Rýdlová, Petr Hodek, Marie Stiborová, Eva Frei, Václav Martínek, Sudan I Is a Potential Carcinogen for Humans Evidence for Its Metabolic Activation and Detoxication by Human Recombinant Cytochrome P450 1A1 and Liver Microsomes Cancer Research. ,vol. 62, pp. 5678- 5684 ,(2002)
Thomas A. Rosenquist, Heidi J. Einolf, Kathleen G. Dickman, Lai Wang, Amanda Smith, Arthur P. Grollman, Cytochrome P450 1A2 Detoxicates Aristolochic Acid in the Mouse Drug Metabolism and Disposition. ,vol. 38, pp. 761- 768 ,(2010) , 10.1124/DMD.110.032201
Tomas Eckschlager, Rene Kizek, Marie Stiborova, Michaela Moserova, Volker M. Arlt, Marketa Martinkova, Radek Indra, Vojtech Adam, Miroslav Sulc, Natalie Kroftova, Modulation of human cytochrome P450 1A1-mediated oxidation of benzo[a]pyrene by NADPH:cytochrome P450 oxidoreductase and cytochrome b5. Neuro endocrinology letters. ,vol. 35, pp. 105- 113 ,(2014)
Min Chen, Likun Gong, Xinming Qi, Guozhen Xing, Yang Luan, Yuanfeng Wu, Ying Xiao, Jun Yao, Yan Li, Xiang Xue, Guoyu Pan, Jin Ren, Inhibition of renal NQO1 activity by dicoumarol suppresses nitroreduction of aristolochic acid i and attenuates its nephrotoxicity Toxicological Sciences. ,vol. 122, pp. 288- 296 ,(2011) , 10.1093/TOXSCI/KFR138